Belzer Alex, Krasowski Matthew D
Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA.
Toxicol Rep. 2024 Mar 16;12:331-337. doi: 10.1016/j.toxrep.2024.03.004. eCollection 2024 Jun.
Methemoglobinemia is a potentially life-threatening condition caused by the formation of methemoglobin, a form of hemoglobin that cannot bind oxygen. While there are some rare congenital causes of methemoglobinemia, most cases are acquired from the effects of specific drugs or environmental exposures. In this retrospective study, we analyzed a large data set of whole blood samples analyzed for methemoglobin at an academic medical center in Midwestern United States that provides both pediatric and adult services. For a 14 year timeframe (May 2009- June 2023), we performed detailed chart analysis of all patients with a methemoglobin concentration of 3.1 % or higher. For an earlier 13 year timeframe (January 1996-April 2009), we performed chart review for all patients with a methemoglobin concentration of 10.0 % or higher. For the 2009-2023 data, dapsone was the most frequent cause of methemoglobinemia (methemoglobin 3.1 % or higher) in both pediatric (73.3 %, 115 clinical encounters, 105 unique patients) and adult (65.3 %, 195 clinical encounters, 190 unique patients) populations. Inhaled nitric oxide as medical therapy was the next most frequent cause in both pediatric (18.1 %) and adult (13.2 %) populations. Causes associated with two or more unique episodes with methemoglobin concentrations of 10.0 % and higher included the following: dapsone (n = 40 episodes), benzocaine (n = 10), recreational use of amyl or isobutyl nitrite (n = 3), suicide attempt with sodium nitrite (n = 3 with 1 fatality; all 3 cases within last 3 years), food contaminated with nitrates (n = 2), and sepsis (n = 2). A total of 18 patients received treatment with methylene blue including 5 cases associated with benzocaine and all of the cases associated with amyl nitrite, isobutyl nitrite, sodium nitrite, and contaminated food. Only 3 patients with dapsone-associated methemoglobinemia received methylene blue, reflecting primary management by dose reduction or discontinuation of drug. Overall, our data reinforce previous studies showing dapsone, inhaled nitric oxide, and nitrites as common agents causing methemoglobinemia in a patient population seen at a medical center. Our data also are consistent with recent epidemiology trends showing increase in suicide attempts using sodium nitrite.
高铁血红蛋白血症是一种由高铁血红蛋白形成引起的潜在危及生命的病症,高铁血红蛋白是一种无法结合氧气的血红蛋白形式。虽然高铁血红蛋白血症有一些罕见的先天性病因,但大多数病例是由特定药物的作用或环境暴露所致。在这项回顾性研究中,我们分析了美国中西部一家提供儿科和成人服务的学术医疗中心对全血样本进行高铁血红蛋白分析的大量数据集。在14年的时间范围内(2009年5月至2023年6月),我们对所有高铁血红蛋白浓度为3.1%或更高的患者进行了详细的病历分析。在更早的13年时间范围内(1996年1月至2009年4月),我们对所有高铁血红蛋白浓度为10.0%或更高的患者进行了病历审查。对于2009 - 2023年的数据,氨苯砜是儿科(73.3%,115次临床就诊,105名独特患者)和成人(65.3%,195次临床就诊,190名独特患者)人群中高铁血红蛋白血症(高铁血红蛋白3.1%或更高)最常见的病因。吸入一氧化氮作为药物治疗是儿科(18.1%)和成人(13.2%)人群中第二常见的病因。与两次或更多次高铁血红蛋白浓度为10.0%及更高的独特发作相关的病因包括:氨苯砜(n = 40次发作)、苯佐卡因(n = 10)、娱乐性使用亚硝酸戊酯或亚硝酸异丁酯(n = 3)、亚硝酸钠自杀未遂(n = 3,1例死亡;所有3例均在过去3年内)、硝酸盐污染的食物(n = 2)和败血症(n = 2)。共有18名患者接受了亚甲蓝治疗,其中包括5例与苯佐卡因相关的病例以及所有与亚硝酸戊酯、亚硝酸异丁酯、亚硝酸钠和受污染食物相关的病例。只有3例氨苯砜相关的高铁血红蛋白血症患者接受了亚甲蓝治疗,这反映了通过减少剂量或停用药物进行的主要治疗。总体而言,我们的数据强化了先前的研究,表明氨苯砜、吸入一氧化氮和亚硝酸盐是医疗中心所见患者群体中导致高铁血红蛋白血症的常见因素。我们的数据也与最近的流行病学趋势一致,显示使用亚硝酸钠自杀未遂的情况有所增加。